InspireMD (NSPR) Tops Q2 EPS by 19c

InspireMD (NASDAQ: NSPR) reported Q2 EPS of ($0.24), $0.19 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.8 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Sun Communities names Ileana McAlary as general counsel and EVP
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target